Skip to main content
Top
Published in: Tumor Biology 7/2016

01-07-2016 | Original Article

MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway

Authors: Chen Lv, Yuehan Hao, Guanjun Tu

Published in: Tumor Biology | Issue 7/2016

Login to get access

Abstract

Osteosarcoma, which accounts for 5 % of pediatric tumor, remains the major cause of death among orthopedic malignancies. However, the factors associated with its malignant biological behavior are still poorly understood. MicroRNAs are a class of small noncoding RNAs, which have been considered to associate with malignant progression including cell differentiation, proliferation, apoptosis, invasion, and distant metastasis. In our research, we found that microRNA-21 (miR-21) was significantly overexpressed in human osteosarcoma cell line MG63 compared to human fetal osteoblastic cell line hFOB1.19 by using quantitative real-time polymerase chain reaction (qRT-PCR). Moreover, miR-21 overexpression in MG63 caused a significant raise in cell proliferation and invasion and a significant reduction in cell apoptosis. However, miR-21 underexpression in MG63 caused an opposite result. Western blotting displayed that proteins related with proliferation, apoptosis, and invasion were significantly changed in different groups, respectively. Furthermore, we demonstrated that PTEN may be a potential target of miR-21 in MG63 cells and miR-21 could activate PI3K/Akt pathway by suppressing PTEN expression. In summary, our findings suggested that miR-21 played an active role in osteosarcoma and it could predict the occurrence and development of osteosarcoma.
Literature
1.
go back to reference Endo-Munoz L, Cumming A, Sommerville S, Dickinson I, Saunders NA. Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. Br J Cancer. 2010;103:73–81.CrossRefPubMedPubMedCentral Endo-Munoz L, Cumming A, Sommerville S, Dickinson I, Saunders NA. Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. Br J Cancer. 2010;103:73–81.CrossRefPubMedPubMedCentral
2.
go back to reference Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, et al. Osteosarcoma: the same old drugs or more? J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:3102–3. author reply 3104–3105.CrossRef Bielack SS, Marina N, Ferrari S, Helman LJ, Smeland S, Whelan JS, et al. Osteosarcoma: the same old drugs or more? J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:3102–3. author reply 3104–3105.CrossRef
3.
go back to reference Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137:89–99.CrossRefPubMed Gill J, Ahluwalia MK, Geller D, Gorlick R. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137:89–99.CrossRefPubMed
5.
go back to reference Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3:83–92.PubMedPubMedCentral Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3:83–92.PubMedPubMedCentral
6.
go back to reference Soutto M, Chen Z, Saleh MA, Katsha A, Zhu S, Zaika A, et al. TFF1 activates p53 through down-regulation of miR-504 in gastric cancer. Oncotarget. 2014;5:5663–73.CrossRefPubMedPubMedCentral Soutto M, Chen Z, Saleh MA, Katsha A, Zhu S, Zaika A, et al. TFF1 activates p53 through down-regulation of miR-504 in gastric cancer. Oncotarget. 2014;5:5663–73.CrossRefPubMedPubMedCentral
7.
go back to reference Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, et al. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Int J Clin Exp Pathol. 2015;8:727–34.PubMedPubMedCentral Guan Y, Chen L, Bao Y, Pang C, Cui R, Li G, et al. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma. Int J Clin Exp Pathol. 2015;8:727–34.PubMedPubMedCentral
8.
go back to reference Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334:1351–8.CrossRefPubMed Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun. 2005;334:1351–8.CrossRefPubMed
9.
go back to reference Zhang X, Nie Y, Du Y, Cao J, Shen B, Li Y. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2012;33:1589–97.CrossRef Zhang X, Nie Y, Du Y, Cao J, Shen B, Li Y. MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2012;33:1589–97.CrossRef
10.
go back to reference Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, et al. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56:220–6.CrossRefPubMed Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, et al. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56:220–6.CrossRefPubMed
11.
go back to reference Jianwei Z, Fan L, Xiancheng L, Enzhong B, Shuai L, Can L. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2013;34:3331–7.CrossRef Jianwei Z, Fan L, Xiancheng L, Enzhong B, Shuai L, Can L. MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2013;34:3331–7.CrossRef
12.
go back to reference Wang L, Shao J, Zhang X, Xu M, Zhao J. MicroRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2015;36:3911–7.CrossRef Wang L, Shao J, Zhang X, Xu M, Zhao J. MicroRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2015;36:3911–7.CrossRef
13.
go back to reference Cui SQ, Wang H: MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Tumour biology: J Int Soc Oncodevelopmental Biol Med. 2015 Cui SQ, Wang H: MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2. Tumour biology: J Int Soc Oncodevelopmental Biol Med. 2015
14.
15.
go back to reference Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647–58.CrossRefPubMedPubMedCentral Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647–58.CrossRefPubMedPubMedCentral
16.
go back to reference Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res. 2011;42:281–90.CrossRefPubMed Wang ZX, Lu BB, Wang H, Cheng ZX, Yin YM. MicroRNA-21 modulates chemosensitivity of breast cancer cells to doxorubicin by targeting PTEN. Arch Med Res. 2011;42:281–90.CrossRefPubMed
17.
go back to reference Liu ZL, Wang H, Liu J, Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem. 2013;372:35–45.CrossRefPubMed Liu ZL, Wang H, Liu J, Wang ZX. MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem. 2013;372:35–45.CrossRefPubMed
18.
go back to reference Lei M, Xie W, Sun E, Sun Y, Tian D, Liu C, et al. MicroRNA-21 regulates cell proliferation and migration and cross talk with PTEN and P53 in bladder cancer. DNA Cell Biol. 2015;34:626–32.CrossRefPubMed Lei M, Xie W, Sun E, Sun Y, Tian D, Liu C, et al. MicroRNA-21 regulates cell proliferation and migration and cross talk with PTEN and P53 in bladder cancer. DNA Cell Biol. 2015;34:626–32.CrossRefPubMed
19.
go back to reference Yang Y, Yang JJ, Tao H, Jin WS. MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation. J Physiol Biochem. 2015;71:59–68.CrossRefPubMed Yang Y, Yang JJ, Tao H, Jin WS. MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation. J Physiol Biochem. 2015;71:59–68.CrossRefPubMed
21.
go back to reference Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, et al. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A. 2012;109:5316–21.CrossRefPubMedPubMedCentral Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, et al. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A. 2012;109:5316–21.CrossRefPubMedPubMedCentral
22.
go back to reference Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28486.CrossRefPubMedPubMedCentral Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One. 2011;6:e28486.CrossRefPubMedPubMedCentral
23.
go back to reference Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen J, et al. Up-regulation of mir-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem. 2011;286:19127–37.CrossRefPubMedPubMedCentral Gong C, Yao Y, Wang Y, Liu B, Wu W, Chen J, et al. Up-regulation of mir-21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem. 2011;286:19127–37.CrossRefPubMedPubMedCentral
24.
go back to reference Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2011;28:1469–74.CrossRefPubMed Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol. 2011;28:1469–74.CrossRefPubMed
25.
go back to reference Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019–26.PubMedPubMedCentral Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. MicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019–26.PubMedPubMedCentral
26.
go back to reference Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S, Navab R. MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One. 2014;9:e103698.CrossRefPubMedPubMedCentral Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S, Navab R. MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One. 2014;9:e103698.CrossRefPubMedPubMedCentral
27.
go back to reference Magro G, Brancato F, Musumeci G, Alaggio R, Parenti R, Salvatorelli L. Cyclin D1 is a useful marker for soft tissue Ewing’s sarcoma/peripheral Primitive Neuroectodermal Tumor in children and adolescents: a comparative immunohistochemical study with rhabdomyosarcoma. Acta Histochem. 2015;117:460–7.CrossRefPubMed Magro G, Brancato F, Musumeci G, Alaggio R, Parenti R, Salvatorelli L. Cyclin D1 is a useful marker for soft tissue Ewing’s sarcoma/peripheral Primitive Neuroectodermal Tumor in children and adolescents: a comparative immunohistochemical study with rhabdomyosarcoma. Acta Histochem. 2015;117:460–7.CrossRefPubMed
28.
go back to reference Zhang C, Zhao Y, Zeng B. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2. Cancer Biomark: Section A Dis Markers. 2012;12:155–67.CrossRef Zhang C, Zhao Y, Zeng B. Enhanced chemosensitivity by simultaneously inhibiting cell cycle progression and promoting apoptosis of drug-resistant osteosarcoma MG63/DXR cells by targeting Cyclin D1 and Bcl-2. Cancer Biomark: Section A Dis Markers. 2012;12:155–67.CrossRef
29.
go back to reference Liu F, Zheng S, Liu T, Liu Q, Liang M, Li X, et al. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway. Mol Cell Biochem. 2013;381:115–25.CrossRefPubMed Liu F, Zheng S, Liu T, Liu Q, Liang M, Li X, et al. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway. Mol Cell Biochem. 2013;381:115–25.CrossRefPubMed
30.
go back to reference Guo Q, Zhang H, Zhang L, He Y, Weng S, Dong Z, et al. MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19. Int J Clin Exp Med. 2015;8:8835–41.PubMedPubMedCentral Guo Q, Zhang H, Zhang L, He Y, Weng S, Dong Z, et al. MicroRNA-21 regulates non-small cell lung cancer cell proliferation by affecting cell apoptosis via COX-19. Int J Clin Exp Med. 2015;8:8835–41.PubMedPubMedCentral
31.
go back to reference Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155–60.CrossRefPubMed Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, et al. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155–60.CrossRefPubMed
32.
go back to reference Zhang M, Zhang HQ, Xue SB. Effect of Bcl-2 and caspase-3 on calcium distribution in apoptosis of HL-60 cells. Cell Res. 2000;10:213–20.CrossRefPubMed Zhang M, Zhang HQ, Xue SB. Effect of Bcl-2 and caspase-3 on calcium distribution in apoptosis of HL-60 cells. Cell Res. 2000;10:213–20.CrossRefPubMed
33.
go back to reference Lee HJ, Lee EK, Seo YE, Shin YH, Kim HS, Chun YH, et al. Roles of Bcl-2 and caspase-9 and -3 in cd30-induced human eosinophil apoptosis. J Microbiol, Immunol, Infection = Wei mian yu gan ran za zhi 2015 Lee HJ, Lee EK, Seo YE, Shin YH, Kim HS, Chun YH, et al. Roles of Bcl-2 and caspase-9 and -3 in cd30-induced human eosinophil apoptosis. J Microbiol, Immunol, Infection = Wei mian yu gan ran za zhi 2015
34.
go back to reference Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–9.CrossRefPubMed Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350–9.CrossRefPubMed
35.
go back to reference Han M, Wang F, Gu Y, Pei X, Guo G, Yu C, et al. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-beta pathways. Oncol Rep 2015 Han M, Wang F, Gu Y, Pei X, Guo G, Yu C, et al. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-beta pathways. Oncol Rep 2015
36.
go back to reference Swarnakar S, Paul S, Singh LP, Reiter RJ. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res. 2011;50:8–20.CrossRefPubMed Swarnakar S, Paul S, Singh LP, Reiter RJ. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res. 2011;50:8–20.CrossRefPubMed
37.
go back to reference Redondo-Munoz J, Jose Terol M, Garcia-Marco JA, Garcia-Pardo A. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood. 2008;111:383–6.CrossRefPubMed Redondo-Munoz J, Jose Terol M, Garcia-Marco JA, Garcia-Pardo A. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood. 2008;111:383–6.CrossRefPubMed
38.
go back to reference Fromigue O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 2008;283:30549–56.CrossRefPubMedPubMedCentral Fromigue O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem. 2008;283:30549–56.CrossRefPubMedPubMedCentral
39.
go back to reference Jin J, Cai L, Liu ZM, Zhou XS. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asia Pac J Cancer Prev: Apjcp. 2013;14:3681–4.CrossRef Jin J, Cai L, Liu ZM, Zhou XS. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asia Pac J Cancer Prev: Apjcp. 2013;14:3681–4.CrossRef
40.
go back to reference Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–7.CrossRefPubMed Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275:1943–7.CrossRefPubMed
41.
go back to reference Hager M, Haufe H, Kemmerling R, Mikuz G, Kolbitsch C, Moser PL. PTEN expression in renal cell carcinoma and oncocytoma and prognosis. Pathology. 2007;39:482–5.CrossRefPubMed Hager M, Haufe H, Kemmerling R, Mikuz G, Kolbitsch C, Moser PL. PTEN expression in renal cell carcinoma and oncocytoma and prognosis. Pathology. 2007;39:482–5.CrossRefPubMed
42.
go back to reference Yuan H, Gao Y: MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression. Oncol Rep. 2015 Yuan H, Gao Y: MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression. Oncol Rep. 2015
43.
go back to reference Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. MicroRNA-93 promotes cell proliferation via targeting of PTEN in osteosarcoma cells. J Exp Clin Cancer Res: Cr. 2015;34:76.CrossRefPubMedPubMedCentral Kawano M, Tanaka K, Itonaga I, Ikeda S, Iwasaki T, Tsumura H. MicroRNA-93 promotes cell proliferation via targeting of PTEN in osteosarcoma cells. J Exp Clin Cancer Res: Cr. 2015;34:76.CrossRefPubMedPubMedCentral
44.
go back to reference Levine RA, Forest T, Smith C. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors. Vet Pathol. 2002;39:372–8.CrossRefPubMed Levine RA, Forest T, Smith C. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors. Vet Pathol. 2002;39:372–8.CrossRefPubMed
45.
go back to reference Shen L, Chen XD, Zhang YH. MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2014;35:2069–74.CrossRef Shen L, Chen XD, Zhang YH. MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol: J Int Soc Oncodevelopmental Biol Med. 2014;35:2069–74.CrossRef
46.
go back to reference Tian K, Di R, Wang L. MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma. Cancer Gene Ther. 2015;22:351–9.CrossRefPubMed Tian K, Di R, Wang L. MicroRNA-23a enhances migration and invasion through PTEN in osteosarcoma. Cancer Gene Ther. 2015;22:351–9.CrossRefPubMed
47.
go back to reference Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat: Rev Commentaries Antimicrob Anticancer Chemother. 2007;10:13–29.CrossRef Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, et al. Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat: Rev Commentaries Antimicrob Anticancer Chemother. 2007;10:13–29.CrossRef
48.
go back to reference Shao XJ, Miao MH, Xue J, Xue J, Ji XQ, Zhu H. The down-regulation of microRNA-497 contributes to cell growth and cisplatin resistance through PI3K/Akt pathway in osteosarcoma. Cell Physiol Biochem: Int J Exp Cellular Physiol, Biochem, Pharmacol. 2015;36:2051–62.CrossRef Shao XJ, Miao MH, Xue J, Xue J, Ji XQ, Zhu H. The down-regulation of microRNA-497 contributes to cell growth and cisplatin resistance through PI3K/Akt pathway in osteosarcoma. Cell Physiol Biochem: Int J Exp Cellular Physiol, Biochem, Pharmacol. 2015;36:2051–62.CrossRef
49.
go back to reference Yan-nan B, Zhao-yan Y, Li-xi L, Jiang Y, Qing-jie X, Yong Z. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun. 2014;443:802–7.CrossRefPubMed Yan-nan B, Zhao-yan Y, Li-xi L, Jiang Y, Qing-jie X, Yong Z. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun. 2014;443:802–7.CrossRefPubMed
50.
go back to reference Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer. 2010;10:27.CrossRefPubMedPubMedCentral Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, et al. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer. 2010;10:27.CrossRefPubMedPubMedCentral
Metadata
Title
MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway
Authors
Chen Lv
Yuehan Hao
Guanjun Tu
Publication date
01-07-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 7/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-4807-6

Other articles of this Issue 7/2016

Tumor Biology 7/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine